Benign Prostatic Hyperplasia
Conditions
Interventions
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Male
Age
50 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for this disease (refer to the diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Benign Prostatic Hyperplasia issued by Canadian Urological Association in 2018): (1) Male patients aged 50 to 85 years; (2) Clinical symptoms: frequent urination, urgent urination, laborious urination, urine dripping, increased nocturnal urination times, severe urination difficulties, may be accompanied by urinary incontinence or urinary retention; (3) Digital rectal examination or prostate color ultrasound indicate enlarged prostate volume; (4) Auxiliary examination suggested that the maximum urinary flow rate was 50ml; Note: Patients with the above items 1, 2 and 3 or both items 4 can be diagnosed as benign prostatic hyperplasia with lower urinary tract symptoms. 2. TCM Diagnosis Reference: in line with the kidney deficiency and blood stasis type of Jinghuang diagnosis: (1) Main symptoms: dripping after urine, frequency of urination, dysuria, enuresis or incontinence, nocturia increased; (2) Second disease: fatigue, small abdomen, perineum, pubic area or lumbosacral and perianal pain, waist and knee acid and soft, fear of cold; (3) Tongue pulse: faint tongue or petechiae, petechiae, thin white moss, pulse heavy astringent; Note: 2 main symptoms and 2 secondary symptoms (one of tongue and pulse symptoms is required), and it can be diagnosed as a miracle-related disease concerning kidney deficiency and blood stasis. 3. Patients diagnosed with prostatic hyperplasia and with lower urinary tract symptoms after surgical treatment; 4. Patients who voluntarily participated and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Have taken drugs that may affect the bladder outlet function in the past 1 month; 2. Patients with acute or severe cardiovascular and cerebrovascular diseases, lung and liver and kidney insufficiency, mental diseases, and cannot cooperate with treatment; 3. Patients with skin infection, skin lesions, wounds and tumors, and those who cannot perform thunder and fire moxibustion; 4. Participating in other trials; 5. Allergic to cephalosporins.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary flow rate; | — |
Countries
China
Contacts
Public ContactGu Chiming
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed